ARTICLE | Clinical News

NicOx to begin Phase I for NO-aspirin

January 27, 2000 8:00 AM UTC

NicOx (NM:Nicox) will begin a U.S. Phase I trial of NCX 4016 ( NO-aspirin) to treat pain and inflammation. Nicox said that preliminary trials in the U.K. have shown NCX 4016 to be safe and tolerable. ...